Richard Torbett MBE

Rebuilding Trust in Pharmaceuticals: Learning from the Trust Placed in Waiters... Recent findings from a YouGov survey indicate a significant trust gap in the UK, particularly among those aged 33-54, who place more trust in the everyday interactions with waiters than in pharmaceutical companies. This stark comparison underscores the urgent need for the pharmaceutical industry to rethink how it engages with the public. Here’s what we can do to close this gap and rebuild trust: 1-Emulate the Personal Touch: Waiters earn trust through personal, attentive service. Similarly, the pharmaceutical industry should strive for more personalized communication. This could include patient-focused services and support that mimic the attentive care people value in everyday service interactions. 2-Showcase Real Impact: It’s crucial that we clearly communicate the effectiveness and benefits of treatments. By transparently sharing success stories and the tangible impacts of our drugs, we can demonstrate their value in a way that resonates as powerfully as personal service does. 3-Enhance Accessibility and Understanding: Just as a menu is designed to be easily understood, information about drugs should be readily accessible and straightforward. Simplifying scientific data and using clear, relatable language can help demystify pharmaceutical products and processes. 4-Strengthen Partnerships with Patient Advocacy Groups (PAGs): Effective collaboration with PAGs can help bridge the gap between pharmaceutical companies and the public. These groups can aid in translating complex medical jargon into everyday language and help convey the benefits and safety of medications. 5-Commit to Transparency: In the hospitality industry, transparency about what goes into food preparation builds trust. Similarly, the pharmaceutical industry needs to be transparent about drug development processes, pricing strategies, and regulatory compliance to combat misinformation and build a foundation of trust. 6-Engage More Directly: Waiters interact directly with customers, offering immediate responses to queries and concerns. We should adopt this approach by being more proactive in engaging with the public through social media, community forums, and public events to address concerns and highlight positive stories. By adopting these strategies, the pharmaceutical industry can work towards establishing a level of trust that rivals the personal, immediate trust people have in their everyday interactions with service professionals like waiters. Building this trust is essential not only for the acceptance of new treatments but for the overall perception of the industry’s role in healthcare. #Pharmaceuticals #HealthcareTrust #PatientEngagement #TransparencyInHealthcare #PublicHealth #TrustBuilding #PharmaCommunications #PatientAdvocacy #HealthcareInnovation #PharmaceuticalIndustry #PatientCentricCare #HealthLiteracy #PublicEngagement #HealthcareAccessibility #PharmaStrategy

2

New edition of British official pharmaceutical standards published. TSO is delighted to publish the 2025 edition of The British Pharmacopoeia (BP), the collection of official standards for UK pharmaceutical substances and medicinal products, on behalf of the Medicines and Healthcare products Regulatory Agency. We are proud to have a long publishing relationship with MHRA and we are focused on making their complex information easier to use and understand. Available as personal online access, hard copy and organisation-wide online access, the new edition has 14 new BP monographs, 32 new Ph. Eur. Monographs and 105 revised BP monographs. Over the past 12 months we have made it easier for users of the BP to find what they need on the website, with a new and improved site design and navigation. We have developed an updated timeline and tracked changes to better visualise changes to monographs, improved online purchase journeys, and made it easier for users to provide feedback and get technical support.  The BP is essential for pharmaceutical manufacturers to comply with the official standards for UK pharmaceutical substances and medical products. #regulatorypublishing #standards #publishing

28

New Spotlight from The Evidence Base®, this month focusing on RWE Guidance, featuring infographics, expert insights and editorial content covering the various guidance documents released by the FDA and others over recent months. #rwe #rwd #realworldevidence #realworlddata #regulation #regulatoryaffairs #hta #healthtechnologyassessment #healthdata #healthequity #healthpolicy

17